Pharm Sci Seminar – Jack Yalowich, PhD
1116 Rennebohm Hall 777 Highland Ave, MadisonDNA Topoisomerase IIα (TOP2α; 170 kDa) is a prominent target for anticancer drugs whose clinical efficacy is often compromised due to acquired chemoresistance.
Stay up-to-date with the latest events, including faculty presentations, career events for students and alumni, and so much more.
DNA Topoisomerase IIα (TOP2α; 170 kDa) is a prominent target for anticancer drugs whose clinical efficacy is often compromised due to acquired chemoresistance.